[Polyneuropathies during COVID-19 epidemics]
- PMID: 34184490
- DOI: 10.17116/jnevro2021121051138
[Polyneuropathies during COVID-19 epidemics]
Abstract
Our review article aimed for analysis of pathogenesis, diagnostyics and treatment of polyneuropathies manifesting in the course of COVID-19. The reasons for hyposmia and taste disturbances are considered in the subjects with this coronavirus infection as well as relationship between these clinical manifestations and severity of the viral infection. Special attention is given to description of autoimmune mechanisms of Guillain-Barré syndrome and polyneuropathies of critical conditions associated with COVID-19. Some data report about clinical deterioration of diabetic and alcoholic neuropathy during the SARS-CoV-2 infection. Inclusion of group B vitamins, together with C and D vitamins, is recommended to the schedules of combined treatment for polyneuropathies in these patients. Early diagnostics of polyneuropathies, especially, Guillain-Barré syndrome, is required during COVID-19 pandemics, thus helping to administer rational therapy and promoting better quality of life in the patients.
Проведен анализ особенностей патогенеза, диагностики и терапии полинейропатий в условиях COVID-19. Рассмотрены причины развития гипосмии и гипогевзии у лиц, переносящих коронавирусную инфекцию, взаимосвязь клинических проявлений с тяжестью вирусного заболевания. Особое внимание уделено описанию аутоиммунных механизмов синдрома Гийена—Барре и полинейропатии критических состояний, ассоциированных с COVID-19. Приведены данные о том, что течение диабетической и алкогольной полинейропатии ухудшается на фоне коронавирусной инфекции. Отмечена необходимость включения витаминов группы В в сочетании с витаминами D и С в комплексную терапию полинейропатии у таких пациентов. В условиях пандемии COVID-19 необходима ранняя диагностика полинейропатий, особенно синдрома Гийена—Барре, что будет способствовать проведению рациональной терапии, улучшению прогноза, качества жизни пациентов.
Keywords: Guillain-Barré syndrome; Neuromultivit; SARS-CoV-2; alcoholic neuropathy; diabetic neuropathy.
Similar articles
-
Guillain-Barré syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature.J Peripher Nerv Syst. 2020 Jun;25(2):204-207. doi: 10.1111/jns.12382. Epub 2020 May 26. J Peripher Nerv Syst. 2020. PMID: 32388880 Free PMC article. Review.
-
Letter to the editor. Concerning the article entitled ''Guillain Barre syndrome associated with COVID-19 infection: A case report".J Clin Neurosci. 2020 Sep;79:257-258. doi: 10.1016/j.jocn.2020.06.025. Epub 2020 Jul 4. J Clin Neurosci. 2020. PMID: 33070907 Free PMC article.
-
Guillain-Barré syndrome in times of pandemics.J Neurol Neurosurg Psychiatry. 2020 Oct;91(10):1027-1029. doi: 10.1136/jnnp-2020-324230. Epub 2020 Jul 30. J Neurol Neurosurg Psychiatry. 2020. PMID: 32732383 Free PMC article. No abstract available.
-
Review article on COVID-19 and Guillain-Barré syndrome.Front Biosci (Schol Ed). 2021 Jun 30;13(1):97-104. doi: 10.52586/S555. Front Biosci (Schol Ed). 2021. PMID: 34256532 Review.
-
Guillain-Barré Syndrome Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Detection and Coronavirus Disease 2019 in a Child.J Pediatric Infect Dis Soc. 2020 Sep 17;9(4):510-513. doi: 10.1093/jpids/piaa086. J Pediatric Infect Dis Soc. 2020. PMID: 32652520 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous